<DOC>
	<DOCNO>NCT00801268</DOCNO>
	<brief_summary>Triptolide approve effective animal model .</brief_summary>
	<brief_title>Randomized Clinical Trial Triptolide Woldifii Autosomal Dominant Polycystic Kidney Disease</brief_title>
	<detailed_description>Randomized</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<mesh_term>Emodin</mesh_term>
	<mesh_term>Triptolide</mesh_term>
	<criteria>Clinically establish ADPKD eGFR &gt; 30ml/min . Chinese nationality Uncontrolled infection NonADPKD complication</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>polycystic kidney disease</keyword>
	<keyword>tripterygium wilfordii</keyword>
</DOC>